.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Chinese Patent Office
Accenture
Merck
US Army
Julphar
Deloitte
Johnson and Johnson
Dow

Generated: January 17, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: MINOCYCLINE HYDROCHLORIDE

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-330-066 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (10631-330-06)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-330-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-30)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-330-05500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-05)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-331-05500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-331-05)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-331-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-331-30)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-331-066 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (10631-331-06)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-332-066 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (10631-332-06)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-332-05500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-332-05)
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922NDARanbaxy Laboratories Inc.10631-332-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-332-30)
Cnty Line PharmsDYNACINminocycline hydrochlorideCAPSULE;ORAL063067ANDAAlvogen, Inc.47781-545-01100 CAPSULE in 1 BOTTLE (47781-545-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Covington
Federal Trade Commission
Harvard Business School
Chinese Patent Office
Fuji
Mallinckrodt
Baxter
Queensland Health

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot